ARRJF (Arjo AB) Common Stock : $8 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Arjo AB Common Stock?

Arjo AB's quarterly common stock increased from Jun. 2024 ($9 Mil) to Sep. 2024 ($9 Mil) but then declined from Sep. 2024 ($9 Mil) to Dec. 2024 ($8 Mil).

Arjo AB's annual common stock increased from Dec. 2022 ($9 Mil) to Dec. 2023 ($9 Mil) but then declined from Dec. 2023 ($9 Mil) to Dec. 2024 ($8 Mil).

Arjo AB Common Stock Historical Data

The historical data trend for Arjo AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arjo AB Common Stock Chart

Arjo AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Common Stock

Get a 7-Day Free Trial

10.88

10.01

8.77

8.87

8.28

Arjo AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Common Stock	Get a 7-Day Free Trial															8.87	8.74	8.68	8.90	8.28

Arjo AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Arjo AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Arjo AB (OTCPK:ARRJF) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

ARJO B:Sweden ARJOBs:UK 0HQ8:UK A39:Germany

Address

Hans Michelsensgatan 10, Malmo, SWE, SE-211 20

Website

https://www.arjo.com

Arjo AB is a supplier of medical devices, services, and solutions in Sweden. It serves its services to private and public institutions with acute care and long-term care. The company's offering includes products and solutions for patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention and diagnostics. It also offers services such as training in connection with product sales. Geographically, it derives a majority of revenue from Western Europe and also has a presence in North America; and the Rest of the World.